BullFrog AI (BFRG) stock jumped 106% after announcing a drug discovery deal with a top-5 pharma firm targeting major ...

BullFrog AI (BFRG) stock surged 101% after securing a commercial partnership with a top 5 pharma company for depression drug target identification.

Multiple SIRS presentations underscore the potential of LB-102 to address positive, negative, and cognitive symptom domains ...

Reported positive results from potentially registrational Phase 2 trial ofLB-102 in schizophrenia Advanced LB-102 into late-stage development in multiple indications with initiation ofa pivotal Phase ...

LB-102 has potential to be the first benzamide approved for schizophrenia in the U.S. NOVA-2 trial to enroll approximately ...

Abstract: Major depressive disorder (MDD) is a common and socially significant psychiatric disorder with extremely complex pathologic mechanisms. In recent years, resting-state functional magnetic ...

aDepartment of Educational Psychology, University of Pretoria, Pretoria, South Africa bDepartment of Geography, Geoinformatics and Meteorology, University of Pretoria, Pretoria, South Africa cSchool ...

Neuronetics, Inc. 2026 turnaround? New CEO Dan Reuvers and the Greenbrook deal drove revenue growth—see key valuation and ...

Background Alcohol use disorder and treatment-resistant depression (TRD) often co-occur, presenting a major clinical challenge with limited effective treatments. However, ketamine produces rapid ...

Understanding what the US spends to treat mental health and substance use disorders (SUD) is important for understanding spending patterns and informing health policy. In this study, we determined ...

Abstract: The current research focus on Major Depressive Disorder (MDD) is a reflection of its significant adverse impact on individuals and society. Structural magnetic resonance imaging (SMRI) is a ...